Treatment of premature ovarian failure trial: description of an ongoing clinical trial

RCT OA: closed CC0 ⤵ 5 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This ongoing clinical trial is designed to compare different forms of estrogen replacement therapy and no treatment for women with premature ovarian failure.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Premature ovarian failure is a relatively common clinical condition, and carries important long-term health consequences. Estrogen replacement is recommended to alleviate unpleasant hypo-estrogenic symptoms and reduce long-term health risks. However, the most suitable form of estrogen replacement, and the exact effects of no treatment, is unknown. Surprisingly, little research has been carried out in this area. We describe the design of an ongoing clinical trial that will address these issues so that we can begin to provide evidence-based care for affected women.

My notes (saved in your browser only)

MeSH descriptors

Contraceptives, Oral, Combined Contraceptives, Oral, Synthetic Estrogen Replacement Therapy Ethinyl Estradiol Levonorgestrel Primary Ovarian Insufficiency Adolescent Adult Bone Density Contraceptives, Oral, Combined Contraceptives, Oral, Synthetic Drug Combinations Estradiol Estradiol Estrogens Estrogens Ethinyl Estradiol Female Humans Levonorgestrel

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

Cited by (4)

References (7)

Cited by (4)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:07:31.877465+00:00
unpaywall
last seen: 2026-10-12T06:33:14.382917+00:00
License: CC0 · commercial use OK